Mandeville Therapeutics
PrivateLast Round
Accelerator
Feb 10, 2026
Total Funding Raised
$100,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Mandeville Therapeutics operates in Healthcare & Life Sciences and is based in Pittsburgh, Pennsylvania. Its latest recorded funding round was an Accelerator round in February 2026.
Mandeville Therapeutics is a biotechnology company developing small-molecule therapies for the treatment of chronic kidney disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mandeville Therapeutics Comparables
Compare Mandeville Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioCity Biopharma | 87% | |
| R1 Therapeutics | 82% | |
| AstraZeneca | 74% |
For institutional investors. Book with your work email.
Mandeville Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Mandeville Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| AlphaLab | Accelerator |
| Innovation Works | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 10, 2026
$100K round led by AlphaLab
For institutional investors. Book with your work email.
Mandeville Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Mandeville Therapeutics's valuation, stock price, and market status.
Is Mandeville Therapeutics a public or private company?
Mandeville Therapeutics is a private company.
What is the current stock price of Mandeville Therapeutics?
Mandeville Therapeutics is a private company, so its shares have no public market price. Caplight tracks Mandeville Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Mandeville Therapeutics worth (valuation)?
Valuation information for Mandeville Therapeutics is not publicly available.
Can I buy Mandeville Therapeutics stock?
Mandeville Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Mandeville Therapeutics's last funding round?
Mandeville Therapeutics's most recent funding round was Accelerator on February 10, 2026.
Who are the main investors in Mandeville Therapeutics?
Key investors in Mandeville Therapeutics include AlphaLab.
Will Mandeville Therapeutics IPO soon?
No public IPO plans have been announced for Mandeville Therapeutics.
How can I track Mandeville Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Mandeville Therapeutics's shares on secondary markets.